loadpatents
name:-0.012684106826782
name:-0.011149883270264
name:-0.00047802925109863
Maxey; Robert James Patent Filings

Maxey; Robert James

Patent Applications and Registrations

Patent applications and USPTO patent grants for Maxey; Robert James.The latest application filed is for "arylsulfonylnaphthalene derivatives as 5ht2a antagonists".

Company Profile
0.9.8
  • Maxey; Robert James - Amersham GB
  • Maxey; Robert James - Harlow Essex
  • Maxey; Robert James - Cambridge GB
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Arylsulfonylnaphthalene derivatives as 5HT.sub.2A antagonists
Grant 7,592,456 - Chambers , et al. September 22, 2
2009-09-22
Arylsulfonylnaphthalene Derivatives As 5Ht2a Antagonists
App 20070281952 - Chambers; Mark Stuart ;   et al.
2007-12-06
Imidazo-triazine derivatives as ligands for gaba receptors
Grant 7,176,203 - Chambers , et al. February 13, 2
2007-02-13
Substituted 1,2,3-triazolo[1,5-a]quinazolines for enhancing cognition
Grant 7,144,887 - Bryant , et al. December 5, 2
2006-12-05
5-HT.sub.2A receptor ligands
Grant 7,094,777 - Chambers , et al. August 22, 2
2006-08-22
Imidazo-pyrimidine derivatives as ligands for GABA receptors
Grant 7,030,128 - Blackaby , et al. April 18, 2
2006-04-18
Imidazo-triazine derivatives as ligands for gaba receptors
App 20060058303 - Chambers; Mark Stuart ;   et al.
2006-03-16
Imidazopyridines pyrimidines and triazines for enhancing cognition as gaba-a-alphas 5 receoptor subtype ligands
App 20060040940 - Bettati; Michela ;   et al.
2006-02-23
Nitrogen substituted 1,2,4-triazolo[3,4-a]phthalazine derivatives for enhancing cognition
Grant 6,900,209 - Chambers , et al. May 31, 2
2005-05-31
Novel 5-HT2A receptor ligands
App 20050101586 - Chambers, Mark Stuart ;   et al.
2005-05-12
Imidazo-pyrimidine derivatives as ligands for gaba receptors
App 20040092533 - Blackaby, Wesley Peter ;   et al.
2004-05-13
Triazolo-pyrimidine derivatives as ligands for gaba receptors
Grant 6,730,681 - Chambers , et al. May 4, 2
2004-05-04
Nitrogen substituted 1,2,4-triazolo[3,4-a]phthalazine derivatives for enhancing cognition
App 20040043982 - Chambers, Mark Stuart ;   et al.
2004-03-04
Substituted 1,2,3-triazolo[1,5-a]quinazolines for enhancing cognition
App 20030125333 - Bryant, Helen Jane ;   et al.
2003-07-03
Triazolo-pyrimidine derivatives as ligands for gaba receptors
App 20030045532 - Chambers, Mark Stuart ;   et al.
2003-03-06
Quinolones and their therapeutic use
Grant 5,891,878 - Beasley , et al. April 6, 1
1999-04-06
3,4-disubstituted-phenylsulphonamides and their therapeutic use
Grant 5,728,712 - Montana , et al. March 17, 1
1998-03-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed